COVID-19 Not Tied to Worse Inflammatory Bowel Disease Outcomes
FRIDAY, Nov. 18, 2022 (HealthDay News) — COVID-19 did not have a long-term impact on the disease course of inflammatory bowel disease (IBD), according to a study published online Nov. 4 in Therapeutic Advances in Gastroenterology.Simon J. Hong, M.D.,…
Learn MoreManifestations of Vertigo Described in Pregnancy
FRIDAY, Nov. 18, 2022 (HealthDay News) — Pregnancy can bring about the onset of or exacerbate audiovestibular disorders, including vertigo, according to a review published online Oct. 1 in Cureus.Noting that vertigo is one of the most common symptoms…
Learn MoreStable Neurodevelopment Seen for Most Children With Familial High Risk for Schizophrenia
FRIDAY, Nov. 18, 2022 (HealthDay News) — Most children at familial high risk for schizophrenia (FHR-SZ) or bipolar disorder (FHR-BP) have stable neurocognitive development, but some transition to a different, usually more impaired, subgroup, accordin…
Learn MoreMind-Controlled Wheelchair Brings New Freedom to People With Paralysis
FRIDAY, Nov. 18, 2022 (HealthDay News) — A severely paralyzed person no longer needs to go through brain surgery to try and steer a motorized wheelchair with their mind, researchers report.Through an electrode-studded cap placed on their head, severa…
Learn MoreAHA News: As Hearts Race Over the World Cup, Playing Soccer Has Its Benefits From Head to Toe
FRIDAY, Nov. 18, 2022 (American Heart Association News) — Soccer is filled with cardiovascular activities that can benefit the brain as well as the heart.From fullbacks sprinting back to prevent a counterattack to midfielders jogging up the other end…
Learn MoreAHA News: Los corazones se aceleran con la Copa Mundial del fútbol, deporte con beneficios de pie a cabeza
VIERNES, 18 de noviembre de 2022 (American Heart Association News) — El fútbol está repleto de actividades cardiovasculares que pueden beneficiar tanto al cerebro como al corazón.Desde los defensores que retroceden a toda carrera para prevenir un con…
Learn MoreFDA Approves First Drug to Delay Onset of Type 1 Diabetes
FRIDAY, Nov. 18, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Thursday approved the first drug that could delay the development of type 1 diabetes (T1D).Teplizumab (Tzield) targets the autoimmune issues that drive the disease, rat…
Learn MoreStudy Takes Long-Term Look at Benefits of Radiation After Breast Lumpectomy
FRIDAY, Nov. 18, 2022 (HealthDay News) — If you’re diagnosed with early breast cancer, treatment often involves breast-conserving surgery followed by chemotherapy, medication and a course of radiation to keep your cancer from coming back. However, li…
Learn More